ICP devices help surgeons save the lives of patients suffering from these injuries with the help of proper treatment and timely intervention. Generally, there are two types of ICP monitors: one provides ICP data, whereas the other is capable of concurrent cerebrospinal fluid drainage.

Market leaders operating in the market have undertaken various organic growth strategies in the neurotoxins market. The intracranial pressure (ICP) monitoring devices market majorly consists of the players Natus Medical Inc; RAUMEDIC AG; Sophysa SA; Integra LifeSciences Holdings Corp; Medtronic Plc; Braincare Desenvolvimento e Inovacao Tecnologica SA; NovaSignal Corp; Digitimer Ltd; Longeviti Neuro Solutions LLC, and Spiegelberg GmbH & Co KG. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals.

Read more: https://www.theinsightpartners.com/reports/intracranial-pressure-icp-monitoring-devices-market